Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974158-25-000005
Filing Date
2025-01-27
Accepted
2025-01-27 16:37:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5617
  Complete submission text file 0001974158-25-000005.txt   7068
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Subject) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39247 | Film No.: 25559592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address
Hohl Benjamin (Reporting) CIK: 0001882764 (see all company filings)

Type: 144